Thrive score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in vista

Stroke

Volumn 44, Issue 12, 2013, Pages 3365-3369

  Flint, Alexander C ^a   Faigeles, Bonnie S ^a   Cullen, Sean P ^a   Kamel, Hooman ^b   Rao, Vivek A ^a   Gupta, Rishi ^c   Smith, Wade S ^d   Bath, Philip M ^e   Donnan, Geoffrey A ^f  

^a Kaiser Permanente ^*  (United States)

^b FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^c GRADY MEMORIAL HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Cerebral hemorrhage; Forecasting; Outcome assessment; Stroke

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FIBRINOLYTIC THERAPY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RANKIN SCALE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STROKE PATIENT; TOTALED HEALTH RISKS IN VASCULAR EVENTS SCORE; TREATMENT OUTCOME;

CEREBRAL HEMORRHAGE; FORECASTING; OUTCOME ASSESSMENT; STROKE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK; SEX FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84889262333     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.002794     Document Type: Article

References (15)

1. Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integerbased score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 2012;78:1916-1922.
2. Strbian D, Meretoja A, Ahlhelm FJ, Pitkäniemi J, Lyrer P, Kaste M, et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology. 2012;78:427-432.
3. Saposnik G, Guzik AK, Reeves M, Ovbiagele B, Johnston SC. Stroke prognostication using age and NIH Stroke Scale: SPAN-100. Neurology. 2013;80:21-28.
4. Saposnik G, Fang J, Kapral MK, Tu JV, Mamdani M, Austin P, et al; Investigators of the Registry of the Canadian Stroke Network (RCSN); Stroke Outcomes Research Canada (SORCan) Working Group. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke. 2012;43:1315-1322.
5. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, et al; SITS Investigators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012;43:1524-1531.
6. Lou M, Safdar A, Mehdiratta M, Kumar S, Schlaug G, Caplan L, et al. The HAT Score: a simple grading scale for predicting hemorrhage after thrombolysis. Neurology. 2008;71:1417-1423.
7. Hallevi H, Barreto AD, Liebeskind DS, Morales MM, Martin-Schild SB, Abraham AT, et al; UCLA Intra-Arterial Therapy Investigators. Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke. 2009;40:1780-1785.
8. Sarraj A. Optimizing prediction scores for poor outcome after intra-arterial therapy for anterior circulation acute ischemic stroke. International Stroke Conference, New Orleans, LA. Stroke. 2013;A205.
9. Flint AC, Cullen SP, Faigeles BS, Rao VA. Predicting long-term outcome after endovascular stroke treatment: the totaled health risks in vascular events score. Am J Neuroradiol. 2010;31:1192-1196.
10. Flint AC, Kamel H, Rao VA, Cullen SP, Faigeles BS, Smith WS. Validation of the Totaled Health Risks in Vascular Events (THRIVE) score for outcome prediction in endovascular stroke treatment. Int J Stroke. August 29, 2012. http://onlinelibrary.wiley.com/doi/10.1111/j. 1747-4949.2012.00872.x/abstract. Accessed July 1, 2013.
11. Kamel H, Patel N, Rao VA, Cullen SP, Faigeles BS, Smith WS, et al. The THRIVE score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial. J Stroke Cerebrovas Dis. November 2, 2012. http://www.strokejournal.org/article/S1052-3057 (12)00311-4/abstract. Accessed July 1, 2013.
12. Ali M, Bath P, Brady M, Davis S, Diener HC, Donnan G, et al; VISTA Steering Committees. Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses. Int J Stroke. 2012;7:133-138.
13. Flint AC, Xiang B, Gupta R, Nogueira RG, Lutsep HL, Jovin TG, et al. The THRIVE Score predicts outcomes with a third-generation endovascular stroke treatment device in the TREVO-2 trial. Stroke. 2013;44:3370-3375.
14. Pexman JH, Barber PA, Hill MD, Sevick RJ, Demchuk AM, Hudon ME, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. Am J Neuroradiol. 2001;22:1534-1542.
15. König IR, Ziegler A, Bluhmki E, Hacke W, Bath PM, Sacco RL, et al; Virtual International Stroke Trials Archive (VISTA) Investigators. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke. 2008;39:1821-1826.